6.3 Drug Recalls, Quarantine Protocols & Safe Disposal
Key Takeaways
Health Canada classifies recalls as Type I (reasonable probability of serious adverse health consequences or death), Type II (temporary or reversible effects, or a remote chance of serious harm), and Type III (not likely to cause any adverse health consequence).
On receiving a recall notice, the technician pulls every unit matching the DIN and lot number from all storage locations, quarantines it, and blocks further dispensing.
Recalls that extend to the consumer level require a dispensing-record audit to identify and promptly contact every patient who received the affected lot.
Expired and damaged stock is segregated in a secure non-dispensing area and returned through licensed return or waste channels, with a destruction record kept.
Since October 1, 2026, a pharmacist or pharmacy technician may destroy controlled substances on site with a health-professional witness and a signed joint declaration, without prior Health Canada approval.
Drug Recalls, Quarantine Protocols & Safe Disposal
Exam Tip: Drug recalls and pharmaceutical waste disposal are heavily regulated under Health Canada's Food and Drugs Act, the Controlled Drugs and Substances Act (CDSA), and provincial environmental legislation. Pharmacy technicians are directly responsible for the operational execution of recalls: identifying matching lots, securing quarantine bins, generating patient audit lists, processing wholesaler returns, and documenting hazardous waste destruction.
Health Canada Drug Recall Classification Framework
A drug recall is an action taken by a manufacturer, distributor, or Health Canada to remove a health product from sale or distribution, or to correct defective labeling or packaging. Recalls may be voluntary (initiated by the market authorization holder) or ordered directly by Health Canada under federal statutory powers.
┌────────────────────────────────────────────────────────┐
│ Health Canada Drug Recall Severity Scale │
└────────────────────────────────────────────────────────┘
┌────────────────────────────────────────────────────┐
│ CLASS I / TYPE I (Highest Severity) │
│ • Reasonable probability of serious adverse health │
│ consequences or death │
│ • Immediate patient notification & retrieval │
└────────────────────────────────────────────────────┘
│
┌────────────────────────────────────────────────────┐
│ CLASS II / TYPE II (Moderate Severity) │
│ • Temporary or medically reversible health effects │
│ • Low probability of serious adverse consequences │
│ • Retail / pharmacy level quarantine & return │
└────────────────────────────────────────────────────┘
│
┌────────────────────────────────────────────────────┐
│ CLASS III / TYPE III (Lowest Severity) │
│ • Not likely to cause any adverse health effects │
│ • Labelling errors, cosmetic defects, packaging │
└────────────────────────────────────────────────────┘
Detailed Recall Classifications
| Recall Class | Health Canada Risk Definition | Representative Clinical Scenarios | Operational Mandate |
|---|---|---|---|
| Class I (Type I) | A situation in which there is a reasonable probability that the use of, or exposure to, a product will cause serious adverse health consequences or death. | • Microbial contamination of a sterile injectable (e.g., Burkholderia in IV fluids).; • Chemical superpotency or wrong active drug in a container.; • Lack of sterility assurance in intrathecal or ophthalmic products. | Immediate removal from stock; audit dispensing logs; contact every patient who received the affected lot; alert prescriber; arrange urgent replacement. |
| Class II (Type II) | A situation in which the use of, or exposure to, a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. | • Subpotency of a solid oral non-critical drug.; • Presence of non-pathogenic particulate matter in oral liquid.; • Missing cautionary warning label that does not pose immediate life threat. | Quarantine all pharmacy stock; pull from automated dispensing cabinets; return to wholesaler; patient notification conducted on individual clinical risk assessment. |
| Class III (Type III) | A situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences. | • Minor typographical errors on outer carton text.; • Faulty blister packaging that does not compromise chemical stability.; • Smudged or partially illegible lot number printing. | Quarantine on-hand inventory; return to distributor; patient outreach generally not required. |
Levels (Depth) of Recall
- Wholesale Level: Recall stops at distributors and wholesale warehouses; the product has not yet reached retail or hospital pharmacies.
- Retail / Hospital Level: Recall reaches pharmacies, clinics, physician offices, and long-term care facilities; inventory must be removed from dispensing shelves.
- Consumer / Patient Level: Recall extends directly to the end user; pharmacies must track down patients who received the dispensed medication.
Pharmacy Execution of Drug Recalls: Step-by-Step
When a recall notice arrives via wholesaler transmission, Health Canada advisory, or corporate head office directive, the pharmacy technician must systematically execute the following protocol:
- Verify Recall Parameters:
- Note the exact Brand Name, Generic Name, Dosage Form, Strength, 8-digit Drug Identification Number (DIN), and specific Lot/Batch Numbers affected.
- Confirm the Depth of Recall (Class I, II, or III; retail vs. consumer level).
- Search All Physical Inventory Locations:
- Dispensary active stock shelves.
- Fast-mover counting carousels and automated tablet packagers.
- Automated Dispensing Cabinets (ADCs: Pyxis, Omnicell) across all nursing units.
- Emergency crash carts, code blue trays, and floor stock kits.
- Compounding cleanrooms and pre-packing areas.
- Refrigerators, freezers, and secure narcotic vaults.
- Isolate and Quarantine Stock:
- Immediately pull all units matching the affected DIN and lot number.
- Place units inside a dedicated, secure non-dispensing holding container.
- Attach prominent physical labeling: "RECALLED PRODUCT — DO NOT DISPENSE / QUARANTINED."
- Audit Dispensing History (Patient Tracing):
- Query the Pharmacy Management System (PMS) for all prescriptions filled using the affected DIN and lot number across the recall's effective timeframe.
- In Class I recalls, generate an immediate patient contact list. Technicians and pharmacists contact each patient by telephone, explain the recall reason, advise them to cease taking the medication, and coordinate an immediate safe replacement.
- Documentation and Reconciliation:
- Complete the manufacturer's or wholesaler's official Recall Response Form, recording total packages purchased, quantity dispensed, quantity quarantined, and quantity destroyed/returned.
- File all documentation in the pharmacy's recall records for inspection, for the retention period your province requires.
Reverse Distribution & Medication Returns
Pharmacies cannot simply put unsold, expired or recalled pharmaceuticals in ordinary garbage. They use manufacturer and wholesaler return programs, and licensed pharmaceutical waste contractors for items that are not returnable.
Operational Flow of Reverse Distribution
- Inventory Sorting: Expired and short-dated medications are sorted into returnable (eligible for manufacturer financial credit) versus non-returnable categories.
- Manifest Generation: Technicians generate electronic return authorizations (RA), detailing DINs, package sizes, full container vs. partial container counts, lot numbers, and wholesale acquisition costs (WAC).
- Controlled Chain of Custody: Reverse distributors provide tamper-evident containers and specialized logistics for shipping hazardous and non-hazardous products.
- Certificate of Destruction: Upon arrival at the processing facility, items ineligible for credit are destroyed via high-temperature incineration, and a legally binding Certificate of Destruction is returned to the pharmacy.
Safe Disposal and Destruction of Pharmaceuticals
Disposal protocols depend on whether medications represent post-consumer household returns, expired institutional stock, controlled substances, or hazardous cytotoxic materials.
┌────────────────────────────────────────────────────────┐
│ Pharmaceutical Waste Management Pathways │
├──────────────────────────┬─────────────────────────────┤
│ Post-Consumer Returns │ Health Products Stewardship │
│ │ Association (HPSA) bins │
├──────────────────────────┼─────────────────────────────┤
│ Controlled Substances │ CSR s. 110: on-site with a │
│ (Narcotics / Targeted) │ witness, or licensed dealer │
├──────────────────────────┼─────────────────────────────┤
│ Hazardous / Cytotoxic │ Cytotoxic-labelled bins; │
│ Waste (Antineoplastics) │ high-heat incineration │
├──────────────────────────┼─────────────────────────────┤
│ Non-Controlled Stock │ Reverse distributor │
│ (Expired solid/liquid) │ chemical neutralization │
└──────────────────────────┴─────────────────────────────┘
1. Post-Consumer Household Returns (Take-Back Programs)
- Community pharmacies participate in provincial take-back initiatives operated by the Health Products Stewardship Association (HPSA) (e.g., Ontario Medications Return Program [OMRP], British Columbia Medications Return Program).
- Patient Counseling: Patients are instructed to return expired prescription drugs, OTCs, and natural health products to prevent accidental poisoning, diversion, and ecological contamination of municipal waterways.
- Collection Mechanics: Returned medications are deposited directly into tamper-evident, sealed collection barrels located behind the pharmacy counter. Pharmacy staff must never re-dispense, inspect for reuse, or transfer medications from customer return bins.
2. Controlled Substances Destruction (Controlled Substances Regulations, s. 110)
Since October 1, 2026, the CSR allows a pharmacy to either send controlled substances to a licensed dealer (the supplier or a dealer specialized in destruction) or destroy them on site:
- Who destroys: Destruction in a pharmacy may be carried out only by a pharmacist or pharmacy technician.
- Witness: Another person must witness it: a pharmacist, pharmacy technician or intern (including hospital staff), a practitioner, or another health professional.
- Method: The substance must be altered or denatured so that consuming it is impossible or improbable, using a method that complies with federal, provincial and municipal environmental laws. Never pour it down a drain or put it in ordinary garbage.
- Declaration and records: Immediately afterward, the person who destroyed it and the witness sign and date a joint declaration and print their names. The record includes the name of the substance or product (brand, DIN, strength, form, quantity), the method, the date, the address, and the witness's name (CSR s. 121). Records are kept at least two years, and provincial rules may require longer.
- No prior approval: Health Canada approval is no longer needed before a pharmacy destroys unserviceable stock or post-consumer returns.
- Legacy rule: Before October 2026, destruction relied on Health Canada authorization or a subsection 56(1) class exemption, and the BOTSR required a pharmacist or practitioner as witness for targeted substances.
3. Cytotoxic and Hazardous Pharmaceutical Waste
- Identification: Hazardous drugs include antineoplastics (e.g., methotrexate, cyclophosphamide, fluorouracil), immunosuppressants, and reproductive toxins defined by the National Institute for Occupational Safety and Health (NIOSH).
- Containment:
- Cytotoxic Waste Containers: Dedicated, leak-proof and puncture-resistant containers labelled with the cytotoxic symbol. Container colours vary by province and facility, so follow the local waste program.
- Sharps and Bulk Waste: Contaminated sharps go into cytotoxic sharps containers. Unused or partly used hazardous drugs and heavily contaminated materials go into rigid cytotoxic waste containers for incineration.
- Destruction Method: High-temperature incineration (typically exceeding 1,000°C) to fully break down complex polycyclic antineoplastic chemical structures into inert combustion byproducts.
Health Canada issues a recall for an intravenous infusion product after hospital quality testing reveals microbial contamination with Burkholderia cepacia, which can cause life-threatening septic shock in immunocompromised patients. Under Health Canada's classification system, which class does this recall represent?
Class III
Class II
Class I
Class IV
A community pharmacy receives an urgent Class I recall notice for a specific lot of pediatric digoxin elixir. A computer dispensing audit reveals that two patients received bottles from the affected lot two weeks ago. What is the REQUIRED action regarding these two patients?
Wait for the patients or their parents to report adverse side effects before making contact.
Send a notification letter via standard postal mail within 30 days of the recall notice.
Log the dispensed lot numbers in the annual pharmacy quality report without contacting the families.
Contact the parents or caregivers immediately by telephone, instruct them to stop administering the medication, arrange an urgent replacement, and alert the prescriber.
On November 5, 2026, a hospital pharmacy technician is preparing to destroy 10 expired ampoules of morphine 10 mg/mL from the pharmacy's unserviceable stock. Under the Controlled Substances Regulations, which procedure is correct?
Obtain written authorization from Health Canada's Office of Controlled Substances before any destruction can take place, then ship the ampoules to Ottawa.
Break the ampoules and rinse the morphine down the sink, documenting the quantity in the narcotic register without a witness.
Place the intact ampoules in the regular hospital garbage, because injectables cannot be diverted once expired.
Denature the morphine using an environmentally compliant method while a pharmacist, another pharmacy technician, an intern, a practitioner or another health professional witnesses it, then both sign a joint destruction declaration.
Sections you finish are checked off in the contents.